Neil Kumar

Dr. Neil Kumar is the Co-founder, Chief Executive Officer and a member of the Board of Directors at BridgeBio. Dr. Kumar also previously served as the Chief Executive Officer and a member of the Board of Directors of BridgeBio’s now wholly owned affiliate, Eidos Therapeutics. Prior to founding BridgeBio in 2015, he served as the interim Vice President of Business Development at MyoKardia from 2012 to 2014. He also served as a principal at Third Rock Ventures and as an associate principal at McKinsey & Company. Dr. Kumar holds his B.S. and M.S. degrees in chemical engineering from Stanford University and his Ph.D. in chemical engineering from MIT.